Andrew Frazier

Andrew Frazier is a Senior Research Associate at Tempus AI, focusing on developing novel DNA sequencing molecular assays for cancer detection and optimizing related processes using Python and SQL for database development. Previously, Frazier served as a Graduate Research Assistant at The University of Texas Medical Branch, completing a Master’s thesis on GPR37 signaling mechanisms and gaining experience through various laboratory rotations. Earlier research involvement includes work on cancer-related protein inhibition and ecological studies of bacterial interactions in cystic fibrosis at Georgia Institute of Technology, where Frazier also held a managerial role at the information desk. Academic credentials include a Master of Science in Pharmacology and Toxicology from The University of Texas Medical Branch, a Bachelor of Science in Biochemistry from Georgia Institute of Technology, and an Associate of Science in General Studies from Dalton State College.